STEMINA BIOMARKER DISCOVERY, INC.

Basic Information

504 S. Rosa Road
MADISON, WI, 53719-1256

Company Profile

n/a

Additional Details

Field Value
DUNS: 794516695
Hubzone Owned: N
Socially and Economically Disadvantaged: N
Woman Owned: Y
Number of Employees: 11


  1. Identification of Biomarkers of Cardiotoxicity using Metabolomics of Human Plurip

    Amount: $146,666.00

    DESCRIPTION (provided by applicant): Cardiotoxicity, as a result of adverse drug effects, is a serious problem that has yet to be effectively screened prior to patient exposure. Cardiac safety is one ...

    SBIR Phase I 2012 Department of Health and Human Services
  2. SBIR Phase II: Metabolomics of Human Embryonic Stem Cells to Predict Teratogenicity: An Alternative Developmental Toxicity Model

    Amount: $500,000.00

    This Small Business Innovation Research (SBIR) Phase II project will fund a continuation of breakthrough research, development and commercialization of an in vitro assay to help prevent birth defects. ...

    SBIR Phase II 2011 National Science Foundation
  3. Not Available

    Amount: $999,936.00

    Brain tumor stem cells (BTSCs) are a subset population within tumors that are widely believed to be  responsible for tumor recurrence, due to their ability to self-renew, differentiate, migrate, ...

    SBIR Phase II 2010 Department of Health and Human Services
  4. SBIR Phase I: Metabolomics of Human Embryonic Stem Cells to Predict Teratogenicity: An Alternative Developmental Toxicity Model

    Amount: $149,255.00

    This Small Business Innovation Research (SBIR) Phase I project proposes to develop a highly predictive model for assessing the potential of compounds to cause birth defects in the developing human emb ...

    SBIR Phase I 2009 National Science Foundation
  5. SBIR TOPIC 245 "PREDICTIVE EFFICACY SCREENING IN CANCER STEM CELLS USING METABOLO

    Amount: $149,528.00

    Cancer stem cells (CSCs) are a critical tumor subpopulation that may cause local recurrences that plague patients with advanced solid malignancies, even after maximal therapeutic efforts. CSCs can sel ...

    SBIR Phase I 2008 Department of Health and Human Services

Agency Micro-sites

US Flag An Official Website of the United States Government